PARPi after PARPi in epithelial ovarian cancer

The objective of this study was to describe the treatment experience of patients with recurrent epithelial ovarian cancer who are retreated with an inhibitor of poly(ADP-ribose)-polymerase (PARPi). We conducted a multi-institutional, retrospective review of ovarian cancer patients who received ≥2 li...

Full description

Saved in:
Bibliographic Details
Main Authors: K.G. Essel (Author), K. Behbakht (Author), T. Lai (Author), L. Hand (Author), E. Evans (Author), J. Dvorak (Author), K. Ding (Author), G. Konecny (Author), K.N. Moore (Author)
Format: Book
Published: Elsevier, 2021-02-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available